Reactivity of electrochemically concentrated anhydrous [18F]fluoride for microfluidic radiosynthesis of 18F-labeled compounds

被引:31
|
作者
Wong, Rebecca [2 ]
Iwata, Ren [1 ,2 ]
Saiki, Hidekazu [3 ]
Furumoto, Shozo [1 ,4 ]
Ishikawa, Yoichi [1 ]
Ozeki, Eiichi [3 ]
机构
[1] Tohoku Univ, Ctr Cyclotron & Radioisotope, Sendai, Miyagi 9808578, Japan
[2] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan
[3] Shimadzu Co Ltd, Technol Res Lab, Kyoto 6190237, Japan
[4] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 9808575, Japan
基金
日本学术振兴会; 日本科学技术振兴机构;
关键词
Microfluidics; Radiosynthesis; F-18; F-18]fluoride; PET probe; POSITRON-EMISSION-TOMOGRAPHY; PET; FLUOROMISONIDAZOLE;
D O I
10.1016/j.apradiso.2011.09.022
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
In order to demonstrate the usefulness of electrochemically concentrated [F-18]fluoride the reactivity of the [K+/K.222] F-18(-) complex concentrated in an aprotic solvent (ca. 60 mu L) was evaluated via nucleophilic F-18-substitution reactions through radiosynthesis of [F-18]FDG, [F-18]FMISO, [F-18]flumazenil and [F-18]fluoromethyl bromide. The substitutions were carried out in a microfluidic reaction flow cell and the effects of reaction time, temperature, precursor concentration and reaction solvent on the F-18-substitution yields were investigated. The F-18-fluorination yields for the four F-18-labeled compounds under optimized conditions (98% for protected [F-18]FDG, 80% for protected [F-18]FMISO, 20% for [F-18]flumazenil and 60% for [F-18]fluoromethyl bromide) were comparable to or higher than those obtained by conventional means. In this study it is clearly demonstrated that electrochemically concentrated [F-18]fluoride enables microfluidic radiosynthesis by effectively reducing synthesis times and especially by increasing radiochemical yields of products labile at high temperatures. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 50 条
  • [31] Preparation of 18F-Labeled Tracers Targeting Fibroblast Activation Protein via Sulfur [18F]Fluoride Exchange Reaction
    Craig, Austin
    Kogler, Juergen
    Laube, Markus
    Ullrich, Martin
    Donat, Cornelius K.
    Wodtke, Robert
    Kopka, Klaus
    Stadlbauer, Sven
    PHARMACEUTICS, 2023, 15 (12)
  • [32] Radiosynthesis and Tumor MicroPET/CT Imaging of 18F-Fluoroethoxylerianin, an 18F-Labeled Erianin Analogue
    Nie, Hui
    Wang, Nian
    Huang, Jinwen
    Ni, Zhuang
    Xue, Kangyan
    Song, Lixing
    Wang, Mingwei
    Wu, Fanhong
    SYNOPEN, 2022, 06 (02): : 80 - 85
  • [33] Comparison of three 18F-labeled 2-nitroimidazoles for imaging hypoxia in breast cancer xenografts: [18F]FBNA, [18F]FAZA and [18F]FMISO
    dos Santos, Sofia Nascimento
    Wuest, Melinda
    Jans, Hans-Sonke
    Woodfield, Jenilee
    Nario, Arian Perez
    Krys, Daniel
    Dufour, Jennifer
    Glubrecht, Darryl
    Bergman, Cody
    Bernardes, Emerson Soares
    Wuest, Frank
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 124
  • [34] [18F]SuFEx-enabled access to an 18F-Labeled PSMA inhibitor intermediate
    Craig, Austin
    Kogler, Juergen
    Kopka, Klaus
    Stadlbauer, Sven
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S81 - S81
  • [35] Access to 18F-labeled FAP inhibitor variants via [18F]SuFEx reaction
    Kogler, Juergen
    Craig, Austin
    Stadlbauer, Sven
    Kopka, Klaus
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S16 - S16
  • [36] Comparison of [18F]PSMA-1007 with Novel 18F-Labeled PSMA Inhibitor
    Donat, Cornelius
    Craig, Austin
    Kogler, Juergen
    Laube, Markus
    Kopka, Klaus
    Stadlbauer, Sven
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S75 - S76
  • [37] 18F-Labeled Proteins
    Wu, Zhanhong
    Kandeel, Fouad
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2010, 11 (06) : 572 - 580
  • [38] Three structurally related 18F-labeled opioid receptor tracers of different intrinsic activities: Synthesis and evaluation of [18F]FPEO, [18F]FBPN and [18F]FDPN
    Schoultz, Bent
    Reed, Brian
    Marton, Janos
    Hjornevik, Trine
    Willoch, Frode
    Henriksen, Gjermund
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [39] Preparation of a 18F-labeled COX-2 inhibitor via [18F]SuFEx reaction
    Craig, Austin
    Brandt, Florian
    Pietzsch, Jens
    Kopka, Klaus
    Stadlbauer, Sven
    Laube, Markus
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S80 - S80
  • [40] Specific imaging of bacterial infections with 18F-labeled maltotriose ([18F]AAX90)
    Landau, Felicitas
    Axer, Alexander
    Niemann, Silke
    Schelhaas, Sonja
    Gilmour, Ryan
    Schaefers, Michael
    Hermann, Sven
    Konken, Christian
    Faust, Andreas
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 96-97 : S8 - S8